ACTIVE

DR. LEFEVER EN DR. HOEBANX

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

128,7 k €

-8.8% YoY

Gross margin

211,1 k €

-5.5% YoY

Equity

848,6 k €

-0.7% YoY

What does DR. LEFEVER EN DR. HOEBANX do?

DR. LEFEVER EN DR. HOEBANX is a Private limited company incorporated in 2003. Its main activity is: General medical practice activities. Its registered office is in Holsbeek.

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0479.273.832

Incorporation

13/01/2003

Legal form

Private limited company

Registered office

Kraaikant 28
3221 Holsbeek · FlandreSee on map

Contributed capital

18 600,00 €

Latest accounts

31/12/2025

Activities (NACE)

86210General medical practice activities· main 86210General medical practice activities 82990Other business support service activities n.e.c.82990Other business support service activities n.e.c.

Signals

ProfitableSolid equityLow riskPositive cashflowPositive EBITDA

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 20 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007		2006
Income statement
Gross margin	211,1 k €	-5.5%	223,4 k €	+7.2%	208,5 k €	-16.4%	249,4 k €	-12.2%	284 k €	+31.3%	216,3 k €	-7.8%	234,7 k €	+15.8%	202,6 k €	-12.5%	231,5 k €	+12.6%	205,6 k €	+12.1%	183,4 k €	+18.9%	154,3 k €	-21.7%	197,1 k €	-4.5%	206,4 k €	+69.2%	122 k €	-7.0%	131,2 k €	+56.7%	83,7 k €	-23.5%	109,4 k €	-3.6%	113,5 k €	-1.8%	115,6 k €
EBITDA	206,7 k €	-4.4%	216,2 k €	+5.1%	205,8 k €	-17.0%	247,9 k €	-12.2%	282,3 k €	+30.5%	216,3 k €	-7.3%	233,3 k €	+18.3%	197,2 k €	-13.9%	229,1 k €	+11.5%	205,4 k €	+12.7%	182,3 k €	+19.0%	153,2 k €	-21.6%	195,4 k €	-1.4%	198,2 k €	+80.8%	109,6 k €	-10.4%	122,3 k €	+65.9%	73,7 k €	-25.6%	99,1 k €	-5.1%	104,4 k €	-3.9%	108,6 k €
Operating result	194,1 k €	-6.2%	206,9 k €	+4.6%	197,7 k €	-12.9%	226,9 k €	-10.7%	254,2 k €	+34.2%	189,5 k €	-7.8%	205,5 k €	+35.6%	151,5 k €	-18.9%	186,8 k €	+9.7%	170,3 k €	+9.2%	155,9 k €	+23.8%	126 k €	-21.9%	161,3 k €	-5.4%	170,5 k €	+126%	75,4 k €	-2.0%	76,9 k €	+107%	37,1 k €	-44.7%	67 k €	-11.7%	75,9 k €	-5.7%	80,5 k €
Net result	128,7 k €	-8.8%	141,2 k €	+2.2%	138,1 k €	-10.6%	154,5 k €	+4.1%	148,4 k €	+13.5%	130,8 k €	-4.6%	137 k €	+43.3%	95,6 k €	-9.2%	105,3 k €	+27.1%	82,8 k €	+9.9%	75,4 k €	-37.2%	120,1 k €	+7.3%	111,9 k €	+4.4%	107,2 k €	+112%	50,4 k €	-1.5%	51,2 k €	+101%	25,5 k €	-37.0%	40,5 k €	-20.4%	50,9 k €	+4.4%	48,8 k €
Balance sheet
Equity	848,6 k €	-0.7%	854,6 k €	+0.5%	850,4 k €	-23.2%	1,1 M €	+16.2%	953,4 k €	-3.5%	987,5 k €	+1.1%	976,8 k €	+16.3%	839,8 k €	+12.8%	744,2 k €	+16.5%	638,9 k €	+14.9%	556,1 k €	+15.7%	480,7 k €	+33.3%	360,7 k €	+45.0%	248,8 k €	+75.7%	141,6 k €	-53.8%	306,8 k €	+18.9%	258 k €	+9.9%	234,8 k €	+19.4%	196,7 k €	+32.7%	148,2 k €
Total assets	1,1 M €	+2.8%	1 M €	+3.8%	987,9 k €	-16.3%	1,2 M €	+11.9%	1,1 M €	-4.1%	1,1 M €	-5.2%	1,2 M €	+1.6%	1,1 M €	+9.5%	1 M €	+7.1%	974,3 k €	-2.3%	997,2 k €	-1.6%	1 M €	+11.2%	910,6 k €	+7.3%	848,2 k €	+4.2%	813,9 k €	+61.9%	502,8 k €	+15.2%	436,6 k €	+3.1%	423,6 k €	+3.3%	410,2 k €	+11.4%	368,3 k €
Cash	51,3 k €	+37.3%	37,3 k €	-8.5%	40,8 k €	+85.8%	22 k €	-52.2%	45,9 k €	+875%	4,7 k €		–		–		13,3 k €	+98.6%	6,7 k €	+23.5%	5,4 k €	-49.0%	10,7 k €	+3.6%	10,3 k €	-35.9%	16,1 k €	+25.3%	12,8 k €	-23.9%	16,8 k €	-73.3%	63 k €	-45.7%	116 k €	+5.4%	110,1 k €	+46.6%	75,1 k €
Debts	177,7 k €	+4.3%	170,4 k €	+23.9%	137,5 k €	+90.0%	72,4 k €	-28.9%	101,8 k €	-9.7%	112,8 k €	-38.6%	183,5 k €	-39.2%	301,7 k €	+0.9%	298,9 k €	-10.9%	335,4 k €	-23.9%	440,6 k €	-17.2%	531,9 k €	-3.2%	549,5 k €	-8.3%	599,1 k €	-10.4%	668,3 k €	+241%	195,9 k €	+9.9%	178,3 k €	-5.4%	188,5 k €	-11.7%	213,5 k €	-3.0%	220,1 k €
Other
Workforce	–		–		–		–		–		–		–		–		–		–		–		–		–		0,3 ETP	-25.0%	0,4 ETP	+33.3%	0,3 ETP	0.0%	0,3 ETP	-25.0%	0,4 ETP	0.0%	0,4 ETP	+33.3%	0,3 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 2 active · 3 ended

Active mandates

Liesbet Hoebanx

Director · since 27 décembre 2002

Active

Samuel Lefever

Director · since 27 décembre 2002

Active

Ended mandates

Liesbet Hoebanx

Manager

Ended

Lisbet Hoebanx

Manager

Ended

samuel Lefever

Manager

Ended

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Micro model	Micro model	Micro model	Micro model	Micro model	Micro model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	25/08/2026	29/08/2025	06/08/2024	09/08/2023	18/06/2022	21/07/2021
General meeting	27/06/2026	28/06/2025	29/06/2024	22/06/2023	24/05/2022	28/05/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

20 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Micro model	31/12/2025	27/06/2026	25/08/2026	Dutch	PDF
Micro model	31/12/2024	28/06/2025	29/08/2025	Dutch	PDF
Micro model	31/12/2023	29/06/2024	06/08/2024	Dutch	PDF
Micro model	31/12/2022	22/06/2023	09/08/2023	Dutch	PDF
Micro model	31/12/2021	24/05/2022	18/06/2022	Dutch	PDF
Micro model	31/12/2020	28/05/2021	21/07/2021	Dutch	PDF
Micro model	31/12/2019	01/05/2020	27/09/2020	Dutch	PDF
Micro model	31/12/2018	24/06/2019	12/08/2019	Dutch	PDF
Micro model	31/12/2017	29/03/2018	28/05/2018	Dutch	PDF
Micro model	31/12/2016	12/05/2017	04/09/2017	Dutch	PDF
Abridged model	31/12/2015	25/03/2016	05/08/2016	Dutch	PDF
Abridged model	31/12/2014	27/06/2015	31/08/2015	Dutch	PDF
Abridged model	31/12/2013	29/06/2014	30/06/2014	Dutch	PDF
Abridged model	31/12/2012	26/06/2013	08/07/2013	Dutch	PDF
Abridged model	31/12/2011	25/06/2012	11/07/2012	Dutch	PDF
Abridged model	31/12/2010	26/06/2011	07/07/2011	Dutch	PDF
Abridged model	31/12/2009	26/06/2010	08/07/2010	Dutch	PDF
Abridged model	31/12/2008	27/06/2009	16/07/2009	Dutch	PDF
Abridged model	31/12/2007	23/06/2008	11/07/2008	Dutch	PDF
Abridged model	31/12/2006	23/06/2007	19/07/2007	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 2 active · 3 ended

Active mandates

Liesbet Hoebanx

Director · since 27 décembre 2002

Active

Samuel Lefever

Director · since 27 décembre 2002

Active

Ended mandates

Liesbet Hoebanx

Manager

Ended

Lisbet Hoebanx

Manager

Ended

samuel Lefever

Manager

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates05/01/2024
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - DIVERSEN - DOEL - ONTSLAGEN - BENOEMINGEN - ALGEMENE VERGADERING
PDF
Mandates25/03/2016
ONTSLAGEN - BENOEMINGEN
PDF
Other14/06/2010
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF
Registered office11/07/2006
MAATSCHAPPELIJKE ZETEL
PDF
Registered office27/02/2003
MAATSCHAPPELIJKE ZETEL
PDF
Other21/01/2003
RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 2025128,7 k €↓
2024
Annual accounts 2024141,2 k €↑
2023
Annual accounts 2023138,1 k €↓
2023
Name changeDr.Levefer en Dr.Hoebanx
2022
Annual accounts 2022154,5 k €↑
2021
Annual accounts 2021148,4 k €↑
2021
Name changeDr.Lefever en Dr.Hoebanx
2020
Annual accounts 2020130,8 k €↓
2019
Annual accounts 2019137 k €↑
2018
Annual accounts 201895,6 k €↓
2017
Annual accounts 2017105,3 k €↑
2016
Annual accounts 201682,8 k €↑
2015
Annual accounts 201575,4 k €↓
2014
Annual accounts 2014120,1 k €↑
2013
Annual accounts 2013111,9 k €↑
2012
Annual accounts 2012107,2 k €↑
2011
Annual accounts 201150,4 k €↓
2010
Annual accounts 201051,2 k €↑
2009
Annual accounts 200925,5 k €↓
2008
Annual accounts 200840,5 k €↓
2007
Annual accounts 200750,9 k €↑
2006
Annual accounts 200648,8 k €
13/01/2003
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

DR. LEFEVER EN DR. HOEBANX

Overview

What does DR. LEFEVER EN DR. HOEBANX do?

Trend over 20 financial years

Indicative valuation

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline